Award Information
Description of original award (Fiscal Year 2011, $143,225)
This project will determine the cross-reactivity, false-positive rate, and false-negative rate for a broad range of designer drugs in commercially available screening immunoassays. Studies will focus on ante-mortem blood specimens using ELISA-based assays and urine specimens using EMIT-based assays.
ca/ncf